Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Image source: Getty Images. What: Shares of Lannett Company, Inc. (NYSE: LCI), a midsized generic drugmaker, packed on 25.2% last month, according to data from S&P Global Market Intelligence.

Founded in 1942, Lannett Company is a Philadelphia-based developer, manufacturer, marketer, and distributor of generic pharmaceuticals for a broad spectrum of indications. The company has seen its ...

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021. "With the ...

About Lannett Company, Inc.: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

The company’s earnings per share and revenue from the same time last year were 64 cents and $170.91 million. While this drop seems like bad Lannett Company news, it isn’t.

Lannett Company, Inc. (LCI) Q2 2022 Earnings Conference Call February 3, 2022 4:30 PM ETCompany ParticipantsRobert Jaffe – Investor RelationsTim Crew – ...

Lannett Company had seen its market cap tumble from $2.5 billion in early 2015 to below $500 million, all before announcing in August 2018 that JSP was walking away.

Welcome to the Lannett Company Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. My name is Adrianne, and I will be your operator for today's call.